In the 2015 State of the Union address, President Barack Obama announced the launch of the Precision Medicine Initiative — a bold new research effort that can be actuated by MD Labs' Rxight, a pharmacogenetic program.
A Forbes contributor on Monday offered an analysis of the recent record high in generics approvals by the Food and Drug Administration’s Office of Generic Drugs, and the importance that speedy approvals can play in helping patients. The analysis notes that speeding up FDA approval through user fee programs can be beneficial both for patients and manufacturers. (Forbes)
The drug is indicated as an adjunct to diet to treat high cholesterol in adults with primary hypercholesterolemia or mixed dyslipidemia, as well as treatment of adults with severe hypertriglyceridemia.
Kenneth Parks will join the company on June 6 and will oversee all of Mylan’s global finance functions, including accounting and control, financial planning and analysis, investor relations, treasury and tax.